S-18986
Prijeđi na navigaciju
Prijeđi na pretragu
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| (S)-2,3-dihidro-[3,4]ciklopentano-1,2,4-benzotiadiazin-1,1-dioksid | |||
| Klinički podaci | |||
| Identifikatori | |||
| ATC kod | nije dodeljen | ||
| PubChem[1][2] | 637863 | ||
| Hemijski podaci | |||
| Formula | C10H12N2O2S | ||
| Mol. masa | 224,279 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | Novi lek u ispitivanju | ||
S-18986 je ampakinski lek koji je srodan sa ciklotiazidom. On ima nootropne i neuroprotektivne efekte u životinjskim studijama. S-18986 indukuje pojavu BDNF i AMPA posredovanog otpuštanja noradrenalina i acetilholina u hipokampusu i frontalnom korteksu mozga.[3][4][5][6][7][8][9][10][11][12]
Reference[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Lockhart B, Iop F, Closier M, Lestage P (August 2000). „(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices”. European Journal of Pharmacology 401 (2): 145–53. DOI:10.1016/S0014-2999(00)00433-7. PMID 10924919.
- ↑ Lebrun C, Pillière E, Lestage P (August 2000). „Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats”. European Journal of Pharmacology 401 (2): 205–12. DOI:10.1016/S0014-2999(00)00429-5. PMID 10924928.
- ↑ Dicou E, Rangon CM, Guimiot F, Spedding M, Gressens P (April 2003). „Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain”. Brain Research 970 (1-2): 221–5. DOI:10.1016/S0006-8993(03)02357-6. PMID 12706264.
- ↑ Rosi S, Giovannini MG, Lestage PJ, Muñoz C, Corte LD, Pepeu G (May 2004). „S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat”. Neuroscience Letters 361 (1-3): 120–3. DOI:10.1016/j.neulet.2003.12.061. PMID 15135908.
- ↑ Bourasset F, Bernard K, Muñoz C, Genissel P, Scherrmann JM (August 2005). „Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat”. Drug Metabolism and Disposition: the Biological Fate of Chemicals 33 (8): 1137–43. DOI:10.1124/dmd.105.004424. PMID 15860654.
- ↑ Béracochéa D, Philippin JN, Meunier S, Morain P, Bernard K (July 2007). „Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil”. Psychopharmacology 193 (1): 63–73. DOI:10.1007/s00213-007-0765-4. PMID 17384936.
- ↑ Marighetto A, Valerio S, Jaffard R, Mormede C, Muñoz C, Bernard K, Morain P (May 2008). „The AMPA modulator S 18986 improves declarative and working memory performances in aged mice”. Behavioural Pharmacology 19 (3): 235–44. DOI:10.1097/FBP.0b013e3282feb0c1. PMID 18469541.
- ↑ Kelly SJ, Bernard K, Muñoz C, Lawrence RC, Thacker J, Grillo CA, Piroli GG, Reagan LP (January 2009). „Effects of the AMPA receptor modulator S 18986 on measures of cognition and oxidative stress in aged rats”. Psychopharmacology 202 (1-3): 225–35. DOI:10.1007/s00213-008-1301-x. PMID 18762915.
- ↑ Gupta SK, Mishra R, Kusum S, Spedding M, Meiri KF, Gressens P, Mani S (April 2009). „GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986”. Cell Death and Differentiation 16 (4): 624–37. DOI:10.1038/cdd.2008.188. PMID 19136940.
- ↑ Destot-Wong KD, Liang K, Gupta SK, Favrais G, Schwendimann L, Pansiot J, Baud O, Spedding M, Lelièvre V, Mani S, Gressens P (September 2009). „The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis”. Neuropharmacology 57 (3): 277–86. DOI:10.1016/j.neuropharm.2009.05.010. PMID 19501111.
